PPBT
Purple Biotech
PPBT
PPBT
14 hedge funds and large institutions have $378K invested in Purple Biotech in 2024 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 2 increasing their positions, 2 reducing their positions, and 2 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
14
Holders Change
+4
Holders Change %
+40%
% of All Funds
0.19%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
6
Increased
2
Reduced
2
Closed
2
Calls
$35K
Puts
$167K
Net Calls
-$132K
Net Calls Change
-$132K
Top Buyers
| 1 |
KWA
Kingswood Wealth Advisors
San Diego,
California
|
$158K |
| 2 |
TSS
Two Sigma Securities
New York
|
$72.1K |
| 3 |
UBS Group
Zurich,
Switzerland
|
$50.6K |
| 4 |
Group One Trading
Chicago,
Illinois
|
$40.2K |
| 5 |
BNP Paribas Financial Markets
Paris,
France
|
$25.2K |
Top Sellers
| 1 |
AC
Armistice Capital
New York
|
$0 |
| 2 |
Morgan Stanley
New York
|
$24K |
| 3 |
JPMorgan Chase & Co
New York
|
$0 |
| 4 |
TRCT
Tower Research Capital (TRC)
New York
|
$1.06K |
